Medpace Holdings, Inc. is a Cincinnati-based clinical research company that provides drug and medical device development services across North America, Europe, and Asia. With a comprehensive suite of services supporting the clinical development process from Phase I to Phase IV, the company caters to various therapeutic areas. In addition to offering clinical development services to the pharmaceutical, biotechnology, and medical device industries, Medpace Holdings, Inc. also provides development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. Furthermore, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Founded in 1992, Medpace Holdings, Inc. is committed to offering comprehensive clinical solutions and support to the medical industry on a global scale.
Medpace's ticker is MEDP
The company's shares trade on the NASDAQ stock exchange
They are based in Cincinnati, Ohio
There are 1001-5000 employees working at Medpace
It is medpace.com/about/our-mission
Medpace is in the Healthcare sector
Medpace is in the Diagnostic Substances industry
The following five companies are Medpace's industry peers: